| scholarly article | Q13442814 |
| P50 | author | Reza Dana | Q16206939 |
| P2093 | author name string | William Stevenson | |
| Jing Hua | |||
| Sunil K Chauhan | |||
| Francisco Amparo | |||
| Zahra Sadrai | |||
| Andre Okanobo | |||
| Yihe Chen | |||
| Thomas H Dohlman | |||
| P2860 | cites work | Antiinflammatory effects of the phosphodiesterase-4 inhibitor cilomilast (Ariflo) in chronic obstructive pulmonary disease | Q44484408 |
| Antiinflammatory therapy for dry eye. | Q44763839 | ||
| Amelioration of murine dry eye disease by topical antagonist to chemokine receptor 2. | Q45930063 | ||
| Modulation of integrin alpha4beta1 (VLA-4) in dry eye disease | Q46209348 | ||
| Inflammation in dry eye. | Q46372528 | ||
| The controlled-environment chamber: a new mouse model of dry eye. | Q46618772 | ||
| Ophthalmologist Perceptions Regarding Treatment of Moderate-to-Severe Dry Eye: Results of a Physician Survey | Q61759590 | ||
| Desiccating Stress Induces T Cell-Mediated Sjogren's Syndrome-Like Lacrimal Keratoconjunctivitis | Q61851332 | ||
| Phosphodiesterase 4 inhibitors reduce human dendritic cell inflammatory cytokine production and Th1-polarizing capacity | Q73529161 | ||
| Cyclosporin A increases tear fluid secretion via release of sensory neurotransmitters and muscarinic pathway in mice | Q77753274 | ||
| Recurrence after topical nonpreserved methylprednisolone therapy for keratoconjunctivitis sicca in Sjögren's syndrome | Q79885702 | ||
| Generation of pathogenic T(H)17 cells in the absence of TGF-β signalling | Q24625230 | ||
| PDE4 inhibitors: current status | Q24651926 | ||
| Changes in corneal epithelial layer inflammatory cells in aqueous tear-deficient dry eye. | Q33486416 | ||
| Phosphodiesterase 4 inhibitors as novel anti-inflammatory agents | Q33695784 | ||
| Regulation of cAMP and cGMP signaling: new phosphodiesterases and new functions | Q33860484 | ||
| Mechanisms of action of cyclosporine. | Q33908049 | ||
| Desiccating stress promotion of Th17 differentiation by ocular surface tissues through a dendritic cell-mediated pathway | Q33938235 | ||
| Characterization of effector T cells in dry eye disease | Q34065949 | ||
| High-frequency topical cyclosporine 0.05% in the treatment of severe dry eye refractory to twice-daily regimen | Q34076208 | ||
| The corneal wound healing response: cytokine-mediated interaction of the epithelium, stroma, and inflammatory cells. | Q34317970 | ||
| Topical omega-3 and omega-6 fatty acids for treatment of dry eye. | Q34749224 | ||
| JNK and ERK MAP kinases mediate induction of IL-1beta, TNF-alpha and IL-8 following hyperosmolar stress in human limbal epithelial cells | Q36380244 | ||
| IL-17 disrupts corneal barrier following desiccating stress. | Q36676135 | ||
| Autoimmunity in dry eye is due to resistance of Th17 to Treg suppression | Q37071969 | ||
| The anti-inflammatory and immunosuppressive effects of glucocorticoids, recent developments and mechanistic insights | Q37732574 | ||
| IL-23 in the pathogenesis of rheumatoid arthritis | Q37736566 | ||
| Roflumilast: first phosphodiesterase 4 inhibitor approved for treatment of COPD. | Q37778289 | ||
| Cyclosporin A inhibits the production of IL-17 by memory Th17 cells from healthy individuals and patients with rheumatoid arthritis | Q39625191 | ||
| Phosphodiesterase (PDE)4 inhibitors: anti-inflammatory drugs of the future? | Q40895430 | ||
| Report of the National Eye Institute/Industry workshop on Clinical Trials in Dry Eyes. | Q40948258 | ||
| Tailoring cAMP-signalling responses through isoform multiplicity | Q41516369 | ||
| Secretion of proinflammatory cytokines by human conjunctival epithelial cells | Q42441794 | ||
| Role of Th17 cells in the immunopathogenesis of dry eye disease | Q42694095 | ||
| Pro- and anti-inflammatory forms of interleukin-1 in the tear fluid and conjunctiva of patients with dry-eye disease | Q43723395 | ||
| The new phosphodiesterase 4 inhibitor roflumilast is efficacious in exercise-induced asthma and leads to suppression of LPS-stimulated TNF-alpha ex vivo | Q43897053 | ||
| P433 | issue | 7 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | eye disease | Q3041498 |
| P304 | page(s) | 3584-3591 | |
| P577 | publication date | 2012-06-14 | |
| P1433 | published in | Investigative Ophthalmology Visual Science | Q6060707 |
| P1476 | title | PDE4 inhibition suppresses IL-17-associated immunity in dry eye disease | |
| P478 | volume | 53 |
| Q50098128 | Corneal Tissue From Dry Eye Donors Leads to Enhanced Graft Rejection. |
| Q90467874 | Increased risk of keratopathy after psoriasis: A nationwide population-based study |
| Q36990222 | Interferon-γ-Induced Unfolded Protein Response in Conjunctival Goblet Cells as a Cause of Mucin Deficiency in Sjögren Syndrome |
| Q55064864 | Pathological conversion of regulatory T cells is associated with loss of allotolerance. |
| Q64066727 | Rebamipide ophthalmic solution modulates the ratio of T helper cell 17/regulatory T cells in dry eye disease mice |
| Q36243207 | Sjögren syndrome: what and where are we looking for? |
| Q36986476 | Spdef null mice lack conjunctival goblet cells and provide a model of dry eye. |
| Q37374838 | T helper cytokines in dry eye disease |
| Q36926074 | The CCR6/CCL20 axis mediates Th17 cell migration to the ocular surface in dry eye disease |
| Q38219053 | The eye: a window of opportunity in rheumatoid arthritis? |
Search more.